nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—CHRM4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00524	0.00524	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00509	0.00509	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00502	0.00502	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00495	0.00495	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00492	0.00492	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0049	0.0049	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00486	0.00486	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00483	0.00483	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00482	0.00482	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00477	0.00477	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00476	0.00476	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00476	0.00476	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00474	0.00474	CbGpPWpGaD
Aclidinium—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Aclidinium—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.0046	0.0046	CbGpPWpGaD
Aclidinium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00456	0.00456	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00456	0.00456	CbGpPWpGaD
Aclidinium—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00455	0.00455	CbGpPWpGaD
Aclidinium—BCHE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00451	0.00451	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—PRKACA—adrenal gland cancer	0.00447	0.00447	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00438	0.00438	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00437	0.00437	CbGpPWpGaD
Aclidinium—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00436	0.00436	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00433	0.00433	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00375	0.00375	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00373	0.00373	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0037	0.0037	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—REN—adrenal gland cancer	0.00358	0.00358	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00353	0.00353	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00352	0.00352	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00349	0.00349	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00347	0.00347	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00333	0.00333	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.0033	0.0033	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—SDHB—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0032	0.0032	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0032	0.0032	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Aclidinium—BCHE—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00315	0.00315	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00314	0.00314	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00307	0.00307	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00303	0.00303	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00301	0.00301	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00288	0.00288	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00285	0.00285	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00281	0.00281	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0028	0.0028	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00276	0.00276	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00269	0.00269	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00268	0.00268	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00261	0.00261	CbGpPWpGaD
Aclidinium—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00261	0.00261	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00254	0.00254	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00253	0.00253	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Aclidinium—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00247	0.00247	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00244	0.00244	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00243	0.00243	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—BRAF—adrenal gland cancer	0.00241	0.00241	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00235	0.00235	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00209	0.00209	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—RRM1—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—SDHD—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—IGF2—adrenal gland cancer	0.00179	0.00179	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00174	0.00174	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00174	0.00174	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00166	0.00166	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00164	0.00164	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00159	0.00159	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00159	0.00159	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MED12—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00144	0.00144	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00142	0.00142	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—POMC—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PRKACA—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000999	0.000999	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000997	0.000997	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.000995	0.000995	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000993	0.000993	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000984	0.000984	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.000953	0.000953	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000952	0.000952	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000949	0.000949	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000939	0.000939	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.000914	0.000914	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GNAS—adrenal gland cancer	0.000913	0.000913	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ABCB1—adrenal gland cancer	0.000896	0.000896	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.000881	0.000881	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.000875	0.000875	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000873	0.000873	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000866	0.000866	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000852	0.000852	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000851	0.000851	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000843	0.000843	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.000836	0.000836	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000815	0.000815	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000739	0.000739	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000737	0.000737	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000733	0.000733	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000729	0.000729	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000726	0.000726	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000724	0.000724	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000717	0.000717	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000702	0.000702	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000702	0.000702	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000689	0.000689	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000671	0.000671	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000669	0.000669	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000662	0.000662	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000638	0.000638	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000616	0.000616	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—POMC—adrenal gland cancer	0.000615	0.000615	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000614	0.000614	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000611	0.000611	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000608	0.000608	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000594	0.000594	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000592	0.000592	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000589	0.000589	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000588	0.000588	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000587	0.000587	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000586	0.000586	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000581	0.000581	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000581	0.000581	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000574	0.000574	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000572	0.000572	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000567	0.000567	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000563	0.000563	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000563	0.000563	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000556	0.000556	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000539	0.000539	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000494	0.000494	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000493	0.000493	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—adrenal gland cancer	0.00049	0.00049	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000488	0.000488	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000473	0.000473	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.00043	0.00043	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000429	0.000429	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000424	0.000424	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00042	0.00042	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000402	0.000402	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000396	0.000396	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000395	0.000395	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000391	0.000391	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000391	0.000391	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.00039	0.00039	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000386	0.000386	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000379	0.000379	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000378	0.000378	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000377	0.000377	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000375	0.000375	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.000332	0.000332	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000318	0.000318	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000283	0.000283	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000282	0.000282	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000279	0.000279	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000279	0.000279	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000267	0.000267	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000224	0.000224	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000223	0.000223	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000221	0.000221	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000188	0.000188	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000188	0.000188	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000186	0.000186	CbGpPWpGaD
